Investigation of the rs722503 Polymorphism in the FLT1 Gene and Its Association with Preeclampsia Susceptibility in the East Azerbaijan Province, Iran
Abstract
Background: Genetic predisposition plays a crucial role in the development of preeclampsia, with the Fms-like tyrosine kinase 1 (FLT1) gene implicated in angiogenesis and endothelial dysfunction, both central to the disease's pathophysiology. This study aimed to investigate the relationship between the rs722503 polymorphism of the FLT1 gene and susceptibility to preeclampsia in pregnant women in East Azerbaijan Province, Iran.
Method: In this case-control study, 24 fetal cord blood samples from pregnant women, including 13 with preeclampsia and 11 healthy controls, were recruited from healthcare centers in East Azerbaijan Province. Genomic DNA was extracted from blood samples, and the rs722503 polymorphism in the FLT1 gene was analyzed using polymerase chain reaction (PCR). The PCR products were then subjected to electrophoresis to observe the desired polymorphism. Statistical analysis was performed to assess the association between the rs722503 polymorphism and preeclampsia risk.
Results: A significant association was found between the rs722503 polymorphism of the FLT1 gene and the risk of preeclampsia. Women with the TT genotype had a higher risk of developing preeclampsia compared to those with the CC genotype (P-value < 0.05). The frequency of the T allele was also significantly higher in the preeclampsia group compared to controls.
Conclusion: The rs722503 polymorphism of the FLT1 gene may be a genetic risk factor for preeclampsia in the population of East Azerbaijan Province. These findings could contribute to early identification of at-risk individuals and potential development of targeted therapeutic strategies.
2. Wu P, Green MMyers JE. Hypertensive disorders of pregnancy. BMJ. 2023;381:e071653.
3. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health. 2014;2(6):e323-e33.
4. Hutcheon JA, Lisonkova SJoseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391-403.
5. Mayrink J, Costa MLCecatti JG. Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction. ScientificWorldJournal. 2018;2018:6268276.
6. Roberts JMEscudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2(2):72-83.
7. Myatt LRoberts JM. Preeclampsia: Syndrome or Disease? Curr Hypertens Rep. 2015;17(11):83.
8. Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, et al. Circulating Angiogenic Factors and the Risk of Preeclampsia. New England Journal of Medicine. 2004;350(7):672-83.
9. Armaly Z, Jadaon JE, Jabbour AAbassi ZA. Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches. Front Physiol. 2018;9:973.
10. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi HUdagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta. 2007;28(5-6):487-97.
11. Chesley LC. History and Epidemiology of Preeclampsia - Eclampsia. Clinical Obstetrics and Gynecology. 1984;27(4).
12. Yong HEJ, Murthi P, Brennecke SPMoses EK. Genetic Approaches in Preeclampsia. Methods Mol Biol. 2018;1710:53-72.
13. van Dijk M, Mulders J, Poutsma A, Könst AA, Lachmeijer AM, Dekker GA, et al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet. 2005;37(5):514-9.
14. Roten LT, Johnson MP, Forsmo S, Fitzpatrick E, Dyer TD, Brennecke SP, et al. Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Eur J Hum Genet. 2009;17(2):250-7.
15. McGinnis R, Steinthorsdottir V, Williams NO, Thorleifsson G, Shooter S, Hjartardottir S, et al. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet. 2017;49(8):1255-60.
16. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-58.
17. Roberts JMCooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001;357(9249):53-6.
18. Srinivas SK, Morrison AC, Andrela CMElovitz MA. Allelic variations in angiogenic pathway genes are associated with preeclampsia. American Journal of Obstetrics and Gynecology. 2010;202(5):445.e1-45.e11.
19. Amin-Beidokhti M, Gholami M, Abedin-Do A, Pirjani R, Sadeghi H, Karamoddin F, et al. An intron variant in the FLT1 gene increases the risk of preeclampsia in Iranian women. Clin Exp Hypertens. 2019;41(8):697-701.
20. Macías-Salas A, Sosa-Macías M, Barragán-Zúñiga LJ, Blanco-Castañeda R, Damiano A, Garcia-Robles R, et al. Preeclampsia association of placental nucleotide variations in eNOS, VEGFA, and FLT-1 genes in Latin American pregnant women. Placenta. 2023;135:1-6.
21. Ramaiya A, Chandra-Mouli V, Both R, Gottert A, Guglielmi S, Beckwith S, et al. Assessing the health, social, educational and economic impact of the COVID-19 pandemic on adolescents in low- and middle-income countries: a rapid review of the literature. Sex Reprod Health Matters. 2023;31(1):2187170.
22. Zhang G, Zhao J, Yi J, Luan YWang Q. Association Between Gene Polymorphisms on Chromosome 1 and Susceptibility to Pre-Eclampsia: An Updated Meta-Analysis. Med Sci Monit. 2016;22:2202-14.
23. Johnson MP, Brennecke SP, East CE, Göring HH, Kent JW, Jr., Dyer TD, et al. Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene. PLoS One. 2012;7(3):e33666.
Files | ||
Issue | Vol 6, No 4 (2023) | |
Section | Original Article | |
DOI | https://doi.org/10.18502/igj.v6i4.17099 | |
Keywords | ||
FLT1 Genetic Association Studies Preeclampsia Single Nucleotide Polymorphism |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |